Spotlight on the 2024 ESC/EACTS management of atrial fibrillation guidelines: 10 novel key aspects

• Published in: Europace (London, England) Vol. 26; no. 12
• Main Authors: Rienstra, Michiel, Tzeis, Stylianos, Bunting, Karina V, Caso, Valeria, Crijns, Harry J G M, De Potter, Tom J R, Sanders, Prashanthan, Svennberg, Emma, Casado-Arroyo, Ruben, Dwight, Jeremy, Guasti, Luigina, Hanke, Thorsten, Jaarsma, Tiny, Lettino, Maddalena, Løchen, Maja-Lisa, Lumbers, R Thomas, Maesen, Bart, Mølgaard, Inge, Rosano, Giuseppe M C, Schnabel, Renate B, Suwalski, Piotr, Tamargo, Juan, Tica, Otilia, Traykov, Vassil, Kotecha, Dipak, Van Gelder, Isabelle C
• Format: Journal Article
• Language: English
• Published: UK Oxford University Press 03.12.2024
• Subjects: Anti-Arrhythmia Agents - therapeutic use; Anticoagulants - therapeutic use; Atrial Fibrillation - diagnosis; Atrial Fibrillation - physiopathology; Atrial Fibrillation - therapy; Cardiology - standards; Catheter Ablation - standards; Comorbidity; Europe; Humans; Practice Guidelines as Topic; Risk Assessment; Risk Factors; State of the Art Review; Stroke - etiology; Stroke - prevention & control; Thromboembolism - etiology; Thromboembolism - prevention & control; Treatment Outcome; Europe; Atrial fibrillation; Management; Guidelines
• ISSN: 1099-5129; 1532-2092; 1532-2092
• DOI: 10.1093/europace/euae298

Abstract Atrial fibrillation (AF) remains the most common cardiac arrhythmia worldwide and is associated with significant morbidity and mortality. The European Society of Cardiology (ESC)/European Association for Cardio-Thoracic Surgery (EACTS) have recently released the 2024 guidelines for the management of AF. This review highlights 10 novel aspects of the ESC/EACTS 2024 Guidelines. The AF-CARE framework is introduced, a structural approach that aims to improve patient care and outcomes, comprising of four pillars: [C] Comorbidity and risk factor management, [A] Avoid stroke and thromboembolism, [R] Reduce symptoms by rate and rhythm control, and [E] Evaluation and dynamic reassessment. Additionally, graphical patient pathways are provided to enhance clinical application. A significant shift is the new emphasis on comorbidity and risk factor control to reduce AF recurrence and progression. Individualized assessment of risk is suggested to guide the initiation of oral anticoagulation to prevent thromboembolism. New guidance is provided for anticoagulation in patients with trigger-induced and device-detected sub-clinical AF, ischaemic stroke despite anticoagulation, and the indications for percutaneous/surgical left atrial appendage exclusion. AF ablation is a first-line rhythm control option for suitable patients with paroxysmal AF, and in specific patients, rhythm control can improve prognosis. The AF duration threshold for early cardioversion was reduced from 48 to 24 h, and a wait-and-see approach for spontaneous conversion is advised to promote patient safety. Lastly, strong emphasis is given to optimize the implementation of AF guidelines in daily practice using a patient-centred, multidisciplinary and shared-care approach, with the simultaneous launch of a patient version of the guideline. Graphical Abstract Graphical Abstract Overview of 10 novel key points in the 2024 ESC/EACTS Guidelines on the management of atrial fibrillation. AF, atrial fibrillation; LAA, left atrial appendage; OAC, oral anticoagulant; pAF, paroxysmal atrial fibrillation.